Welcome to LookChem.com Sign In|Join Free

CAS

  • or

905273-56-5

Post Buying Request

905273-56-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

905273-56-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 905273-56-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,2,7 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 905273-56:
(8*9)+(7*0)+(6*5)+(5*2)+(4*7)+(3*3)+(2*5)+(1*6)=165
165 % 10 = 5
So 905273-56-5 is a valid CAS Registry Number.

905273-56-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name dimethyl 6-(trifluoromethyl)pyridine-2,3-dicarboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:905273-56-5 SDS

905273-56-5Downstream Products

905273-56-5Relevant articles and documents

Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors

Pinard, Emmanuel,Alberati, Daniela,Bender, Markus,Borroni, Edilio,Brom, Virginie,Burner, Serge,Fischer, Holger,Hainzl, Dominik,Halm, Remy,Hauser, Nicole,Jolidon, Synse,Lengyel, Judith,Marty, Hans-Peter,Meyer, Thierry,Moreau, Jean-Luc,Mory, Roland,Narquizian, Robert,Norcross, Roger D.,Schmid, Philipp,Wermuth, Roger,Zimmerli, Daniel

scheme or table, p. 6960 - 6965 (2011/02/16)

Benzoylisoindolines were discovered as a novel structural class of GlyT1 inhibitors. SAR studies and subsequent lead optimization efforts focused primarily on addressing hERG liability and on improving in vivo efficacy resulted in the identification of potent GlyT1 inhibitors displaying excellent selectivity and in vivo PD and PK profiles.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 905273-56-5